Odesivimab Antibody

SKU: orb1980343

Description

Odesivimab (REGN-3471) is a research-grade human monoclonal antibody designed to neutralize the Zaire ebolavirus. It is utilized in antiviral studies to investigate therapeutic mechanisms, supporting both in vitro neutralization assays and in vivo efficacy research in animal models of Ebola virus infection.

Research Area

Infectious Disease & Virology

Images & Validation

−

Key Properties

−

CAS Number	2135632-30-1
MW	146.16 kDa
Purity	99.64% (SEC-HPLC)
Target	Virus Protease

Bioactivity

−

In Vivo	Odesivimab with Atoltivimab and Maftivimab (REGN-3471, 50 mg/kg) were protective against Ebola virus infected rhesus monkey models.
In Vitro	Odesivimab, Atoltivimab and Maftivimab can be combined to form REGN-EB3 with an IC50 value of 0.39 nM, which can be used for Ebola virus research. Odesivimab showed specific binding to soluble viral glycoprotein. Read more...

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

REGN3471, REGN-3471

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Quick Database Links

Gene Symbol

Virus Protease

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols